Catalog No.
CS145016
Species reactivity
Human
Applications
Research Grade Biosimilar
Host species
Human
Isotype
IgG4-kappa
Expression system
Mammalian Cells
Clonality
Monoclonal
Target
Herpes virus entry mediator ligand, LIGHT, CD258, HVEM-L, HVEML, TNFSF14, Tumor necrosis factor ligand superfamily member 14, Herpesvirus entry mediator ligand
Concentration
1mg/ml
Endotoxin level
Please contact the lab for this information.
Purity
>95% purity as determined by SDS-PAGE.
Purification
Protein A/G, purified from cell culture supernatant.
Accession
O43557
Form
Liquid
Storage buffer
0.01M PBS,pH7.4.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -759°C.
Alternate Names
AEVI-002,CERC-002,F-19,MDGN-002,SAR-252067CAS:2427667-03-4
Background
Quisovalimab (AVTX-002; AEVI 002; SAR 252067) is a human monoclonal antibody against LIGHT, a tumor necrosis factor (TNF)-related cytokine (TNFSF14) that plays an important role in acute respiratory distress syndrome (ARDS) and cytokine release syndrome (CRS) COVID-19. Quisovalimab can be used in COVID-19 acute respiratory distress syndrome and other studies.
Note
For research use only. Not for use in clinical or therapeutic applications.
...